Cristina Rondinone
Vice President
Medicine
MedImmune
Netherlands
Biography
Dr. Cristina Rondinone is the Head of Cardiovascular/Metabolic Disease Center (CV/MD) Innovative Medicines unit (iMED) at MedImmune, leading a cross-functional team dedicated to the therapeutic area strategy, prioritization and advancement of the company’s CV/MD portfolio. Dr. Rondinone joined MedImmune in March 2011 as vice president, research & Development, Cardiovascular/Metabolic Diseases. Most recently, Dr. Rondinone served as Head of Metabolic and Vascular Diseases at Hoffmann-La Roche, Inc., where she led drug discovery research for the Metabolic Disease therapeutic area, including diabetes, dyslipidemia, cardiovascular and renal diseases, resulting in a number of compounds and biologics advancing into clinical trials. Dr. Rondinone spent five years at Hoffmann-la Roche in positions of increasing responsibility. Prior to Hoffmann-La Roche, Dr. Rondinone spent six years at Abbott laboratories where she served as Group Leader, Associate Research Fellow and Research Investigator. Dr. Rondinone’s other experience includes working as an Associate Professor in Molecular Medicine at the Department of Internal Medicine at University of Goteborg in Sweden; serving as a Visiting Fellow at the National Institute of Health in the Laboratory of Cellular and Development Biology and the Laboratory of Theoretical and Physical Biology and serving as a Teaching Instructor at the Department of Biological Sciences at Buenos Aires University. Dr. Rondinone brings more than 20 years industry and academia experience in Metabolic Diseases to MedImmune. In addition, she is the author of over 60 peer-reviewed scientific publications and is the author of two books. She is the co-inventor of three granted patents and applications. Dr. Rondinone is the recipient of numerous awards including being nominated and inducted as a Member of the Royal Academy of Pharmacy and Biochemistry in Spain (2010). Dr. Rondinone received her Ph.D. in Biological Sciences from Buenos Aires University and did her Postdoctoral research at the National Institutes of Health in Bethesda, Maryland.
Research Interest
Pharmacy and Biochemistry